Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham P Taylor

Showing results (111-120 of 227) with videos related to

Pageof 23
Sort By:
Frontiers in Public Health|May 27, 2022
"We Need to Translate Research Into Meaningful HTLV Health Policies and Programs": Webinar HTLV World Day 2021Carolina Rosadas, Tatiane Assone, Leandro Sereno, et al.
Cell Chemical Biology|October 3, 2017
Glucose Metabolism and Oxygen Availability Govern Reactivation of the Latent Human Retrovirus HTLV-1Anurag Kulkarni, Manuel Mateus, Cyrille C Thinnes, et al.
Blood|April 20, 2002
High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesisPeter K C Goon, Emmanuel Hanon, Tadahiko Igakura, et al.
AIDS (London, England)|February 11, 2026
Dosing of ritonavir-boosted darunavir for treatment of HIV in pregnancyRebecca Sconza, Graham P Taylor, Luminita Ene, et al.
AIDS (London, England)|December 6, 2024
Proviral HIV DNA sequencing to inform suitability for long-acting injectable cabotegravir/rilpivirineJasmini Alagaratnam, Niall Kelly, Simon Dustan, et al.
AIDS (London, England)|November 7, 2015
The risk of viral rebound in the year after delivery in women remaining on antiretroviral therapySusie Huntington, Claire Thorne, Marie-Louise Newell, et al.
Antimicrobial Agents and Chemotherapy|November 4, 2015
No Need for Lopinavir Dose Adjustment during Pregnancy: a Population Pharmacokinetic and Exposure-Response Analysis in Pregnant and Nonpregnant HIV-Infected SubjectsAhmed Hamed Salem, Aksana Kaefer Jones, Marilia Santini-Oliveira, et al.
AIDS (London, England)|February 25, 2015
Pregnancy is associated with elevation of liver enzymes in HIV-positive women on antiretroviral therapySusie Huntington, Claire Thorne, Marie-Louise Newell, et al.
Blood|April 17, 2014
The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia/lymphomaLucy B Cook, Anat Melamed, Heather Niederer, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|August 14, 2023
Patient research priority setting partnership in human T-cell lymphotropic virus type IAdine Adonis, Anne-Marie Russell, Graham P Taylor, et al.
Pageof 23

Showing results (111-120 of 227) with videos related to

Sort By:
Pageof 23
Frontiers in Public Health|May 27, 2022
"We Need to Translate Research Into Meaningful HTLV Health Policies and Programs": Webinar HTLV World Day 2021Carolina Rosadas, Tatiane Assone, Leandro Sereno, et al.
Cell Chemical Biology|October 3, 2017
Glucose Metabolism and Oxygen Availability Govern Reactivation of the Latent Human Retrovirus HTLV-1Anurag Kulkarni, Manuel Mateus, Cyrille C Thinnes, et al.
Blood|April 20, 2002
High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesisPeter K C Goon, Emmanuel Hanon, Tadahiko Igakura, et al.
AIDS (London, England)|February 11, 2026
Dosing of ritonavir-boosted darunavir for treatment of HIV in pregnancyRebecca Sconza, Graham P Taylor, Luminita Ene, et al.
AIDS (London, England)|December 6, 2024
Proviral HIV DNA sequencing to inform suitability for long-acting injectable cabotegravir/rilpivirineJasmini Alagaratnam, Niall Kelly, Simon Dustan, et al.
AIDS (London, England)|November 7, 2015
The risk of viral rebound in the year after delivery in women remaining on antiretroviral therapySusie Huntington, Claire Thorne, Marie-Louise Newell, et al.
Antimicrobial Agents and Chemotherapy|November 4, 2015
No Need for Lopinavir Dose Adjustment during Pregnancy: a Population Pharmacokinetic and Exposure-Response Analysis in Pregnant and Nonpregnant HIV-Infected SubjectsAhmed Hamed Salem, Aksana Kaefer Jones, Marilia Santini-Oliveira, et al.
AIDS (London, England)|February 25, 2015
Pregnancy is associated with elevation of liver enzymes in HIV-positive women on antiretroviral therapySusie Huntington, Claire Thorne, Marie-Louise Newell, et al.
Blood|April 17, 2014
The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia/lymphomaLucy B Cook, Anat Melamed, Heather Niederer, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|August 14, 2023
Patient research priority setting partnership in human T-cell lymphotropic virus type IAdine Adonis, Anne-Marie Russell, Graham P Taylor, et al.
Pageof 23